Moreover, there are no standardized methods for macrophage detection and different studies have used different markers (e.g., CD68, CD163, or CD206) and staining platforms to make conclusions about the prognostic value of macrophages in invasive breast cancer. Here, CD163 is linked to invasive breast carcinoma.